1448347-49-6 ivosidenib
| Nome del prodotto |
ivosidenib |
| Nome inglese |
ivosidenib; RG120; (2S)-N-{(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide; (S)-N-((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide; (2S)-1-(4-Cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)glycinamide; Glycinamide, 1-(4-cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-, (2S)- |
| Numero CAS |
1448347-49-6 |
| Struttura molecolare |
|
| Densità |
1.51±0.1 g/cm3(Predicted) |
| Punto di fusione |
151-173°C |
| Punto di ebollizione |
854.3±65.0 °C(Predicted) |
| Solubilità in acqua |
氯仿 (微溶) 甲醇 (微溶) |
| Simboli di pericolo |
|
| Codici di Rischio |
|
| Sicurezza Descrizione |
|
|
IT
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR
